Skip to content

Activity and heartrate monitor validation study

Activity and heartrate monitor validation study - Activity and heartrate monitor validation study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43960
Enrollment
31
Registered
2015-10-07
Start date
2016-02-12
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Validatie meeteigenschappen van activiteiten en hartslagmonitor bij gezonde proefpersonen Sedentary behavior suboptimal physical fitness

Interventions

During the controlled measurements subjects are asked to complete various activities (eg. Walking and cycling). During the measurements the activity and heart rate monitor is worn and reference meas

Sponsors

Philips
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Aged more than 18 years old . - Body mass index [body weight (kilograms)] / [height^2 (meters)] between 19 and 35 - Functionally capable

Exclusion criteria

Exclusion criteria: - Suffering from severe chronic disease for which a physician has contraindicated moderate intensity exercise without medical supervision - Function/mobility and or cognitive impairments preventing compliance with the study protocol - Having pacemaker or other implantable electronic devices - Skin issues or wounds in wrist area - Might be, or is, pregnant

Design outcomes

Primary

MeasureTime frame
The primary parameters of the study are: - measurement accuracy of energy expenditure - measurement accuracy of resting heart rate

Secondary

MeasureTime frame
Secondary parameters include assessment of accuracy of other measures: - heartrate - sleep duration - steps counting - activity recognition - respiration rate at rest - sedentary behaviour alert - heart rate recovery, interburst interval and VO2max estimation yes/no Additionally the wear comfort of the device will be evaluated with a questionnaire.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)